Product Description: Miromavimab (M777-16-3) is a anti-rabies virus strain ERAGP ectodomainepitope G-II mAb[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Kansagra K, et al. A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG). Clin Infect Dis. 2021;73(9):e2722-e2728.
CAS Number: 2247163-73-9
Molecular Weight: N/A
Research Area: Infection
Solubility: 10 mM in DMSO
Target: Others